Methyl-[2-pyrrolidin-1-yl-1-(tetrahydro-pyran-4-yl)-ethyl]-amine, 97.0%, 100mg

2-Methylpiperidine-3-carboxylic acid hydrochloride, 95.0%, 1g

Óxido de silicio(IV) en polvo 99,99% -100 malla 250 g

4-[(2,4-dioxo-1,3-thiazolidin-3-yl)methyl]benzoic acid, 95.0%, 2.5g

1-CYCLOPROPYLPIPERIDINE-2,4-DIONE, 95.0%, 1g

(1-propyl-1H-imidazol-2-yl)methanol, 95.0%, 500mg

Methyl 5-formyl-1H-pyrrole-2-carboxylate, 95.0%, 5g

Monoethyl Potassium Malonate>98.0%(T)25g

5-methyl-3-(3-phenoxyphenyl)-4,5-dihydro-1,2-oxazole-5-carboxylic acid, 95.0%, 1g

6-(Trifluoromethyl)benzo[b]thiophene-2-carboxylic acid, 95.0%, 1g

2-Chloro-6-(trifluoromethyl)thiazolo[4,5-b]pyridine, 95.0%, 5g

2-(Hydroxymethyl)nicotinic acid, 98+%, 100mg

Crisol de fusión ROTILABO®, 70 ml, 1 pieza